3
8
Hoehn & Krause
1
1. Samama CM, Diaby M, Fellahi JL, et al. Inhibition of platelet
31. Amato M, de Roche B, von Muralt G. Persistent pulmonary
hypertension in preterm-infants. Padiatr Padol 1986; 21 (1):
25-30
32. Gommers D, Hartog A, van ’t Veen A, et al. Improved oxygen-
ation by nitric oxide is enhanced by prior lung reaeration with
surfactant, rather than positive end-expiratory pressure, in
lung-lavaged rabbits. Crit Care Med 1997; 25: 1868-73
33. Peliowski A, Finer NN, Etches PC, et al. Inhaled nitric oxide
for premature infants after prolonged rupture of the mem-
branes. J Pediatr 1995; 126: 450-3
aggregation by inhaled nitric oxide in patients with acute re-
spiratory distress syndrome. Anesthesiology 1995; 83: 56-65
2. Cheung PY, Salas E, Etches PC, et al. Inhaled nitric oxide and
inhibition of platelet aggregation in critically ill neonates.
Lancet 1998; 351: 1181-2
3. George TN, Johnson KJ, Bates JN, et al. The effect of inhaled
nitric oxide therapy on bleeding time and platelet aggregation
in neonates. J Pediatr 1998; 132: 731-4
4. Miller OI, Gaynor JW, Macrae DJ, et al. Inhaled nitric oxide for
pulmonary hypertension after repair of exomphalos. Arch Dis
Child 1993; 69: 518-20
5. Schranz D, Huth R, Wippermann CF, et al. Nitric oxide and
prostacyclin lower suprasystemic pulmonary hypertension af-
ter cardiopulmonary bypass. Eur J Pediatr 1993; 152: 793-6
6. Journois D, Pouard P, Mauriat P, et al. Inhaled nitric oxide as a
therapy for pulmonary hypertension after operations for con-
genital heart defects. J Thorac Cardiovasc Surg 1994; 107:
1
1
1
1
1
34. Banks BA, Seri I, Ischiropoulos H, et al. Changes in oxygena-
tion with inhaled nitric oxide in severe bronchopulmonary
dysplasia. Pediatrics 1999; 103: 610-8
3
5. Cheung PY, Peliowski A, Robertson CM. The outcome of very
low birth weight neonates. J Pediatr 1998; 133: 735-9
36. Kinsella JP, Walsh FW, Bose CL, et al. Inhaled nitric oxide in
premature neonates with severe hypoxaemic respiratory fail-
ure: a randomised controlled trial. Lancet 1999; 354: 1061-5
1129-35
3
3
3
7. Franco-Belgium Collaborative NO Trial Group. Early com-
pared with delayed inhaled nitric oxide in moderately
hypoxaemic neonates with respiratory failure: a randomised
controlled trial. Lancet 1999; 354: 1066-71
8. Barrington KJ, Finer NN. Inhaled nitric oxide in preterm new-
born infants with respiratory failure (Cochrane review).
Cochrane Library [CDROM and Online]. Issue 1. Oxford:
The Cochrane Collaboration, 1999: review no. 000509
9. Chang LY, Graham JA, Miller FJ, et al. Effects of subchronic
inhalation of low concentrations of nitrogen dioxide: the prox-
imal alveolar region of juvenile and adult rats. Toxicol Appl
Pharmacol 1986; 83: 45-61
1
1
7. Karamanoukian HL, Glick PL, Zayek M, et al. Inhaled nitric
oxide in congenital hypoplasia of the lungs due to diaphrag-
matic hernia or oligohydramnios. Pediatrics 1994; 94: 715-8
8. Hoffman GM, Ross GA, Day SE, et al. Inhaled nitric oxide
reduces the utilization of extracorporeal membrane oxygena-
tion in persistent pulmonary hypertension of the newborn.
Crit Care Med 1997; 25: 352-9
1
2
2
9. Day RW, Lynch JM, White KS, et al. Acute response to inhaled
nitric oxide in newborns with respiratory failure and pulmo-
nary hypertension. Pediatrics 1996; 98: 698-705
0. Barefield ES, Karle VA, Phillips 3rd JB, et al. Inhaled nitric
oxide in term infants with hypoxemic respiratory failure. J
Pediatr 1996; 129: 279-86
1. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multi-
center trial of inhaled nitric oxide and high-frequency oscil-
latory ventilation in severe, persistent pulmonary hypertension
of the newborn. J Pediatr 1997; 131: 55-62
4
4
4
0. Hallman M, Bry K, Turbow R, et al. Pulmonary toxicity asso-
ciated with nitric oxide in term infants with severe respiratory
failure. J Pediatr 1998; 132: 827-9
1. Hoehn T, Huebner J, Paboura E, et al. Effect of therapeutic
concentrations of nitric oxide on bacterial growth in vitro. Crit
Care Med 1998; 26: 1857-62
2. Christou H, Magnani B, Morse DS, et al. Inhaled nitric oxide
does not affect adenosine 5’-diphosphate-dependent platelet
activation in infants with persistent pulmonary hypertension
of the newborn. Pediatrics 1998; 102: 1390-3
2
2. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric
oxide for the early treatment of persistent pulmonary hyper-
tension of the term newborn: a randomized, double-masked,
placebo-controlled, dose-response, multicenter study: the I-
NO/PPHN Study Group. Pediatrics 1998; 101: 325-34
3. Finer NN, Barrington KJ. Nitric oxide in respiratory failure in
the newborn infant. Semin Perinatol 1997; 21: 426-40
4. Finer NN, Barrington KJ. Nitric oxide in respiratory failure in
full-term and nearly full-term newborn infants (Cochrane re-
view). Cochrane Library [CDROM and online]. Issue 1. Ox-
ford: The Cochrane Collaboration, 1999: review no. 000399
5. Goldman AP, Tasker RC, Haworth SG, et al. Four patterns of
response to inhaled nitric oxide for persistent pulmonary hy-
pertension of the newborn. Pediatrics 1996; 98: 706-13
6. Rais Bahrami K, Rivera O, Seale WR, et al. Effect of nitric oxide
in meconium aspiration syndrome after treatment with surfac-
tant. Crit Care Med 1997; 25: 1744-7
4
4
3. Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-
mediated toxicity. Curr Top Microbiol Immunol 1995; 196:
2
2
5
7-73
4. Gries A, Bode C, Peter K, et al. Inhaled nitric oxide inhibits
human platelet aggregation, P-selectin expression, and fibrin-
ogen binding in vitro and in vivo. Circulation 1998; 97 (15):
1
481-7
2
2
2
4
5. Varela AF, Runge A, Ignarro LJ, et al. Nitric oxide and pro-
stacyclin inhibit fetal platelet aggregation: a response similar
to that observed in adults. Am J Obstet Gynecol 1992; 167:
1
599-604
46. Bassenge E. Antiplatelet effects of endothelium-derived relax-
ing factor and nitric oxide donors. Eur Heart J 1991; 12 Suppl.
E: 12-5
47. Huang QW, Sun B, Gao F, et al. Effects of inhaled nitric oxide
and high-frequency ventilation in rabbits with meconium as-
piration. Biol Neonate 1999; 76: 374-82
48. Gessler P, Nebe T, Birle A, et al. A new side effect of inhaled
nitric oxide in neonates and infants with pulmonary hyperten-
sion: functional impairment of the neutrophil respiratory
burst. Intens Care Med 1996; 22: 252-8
49. Iha S, Orita K, Kanno T, et al. Oxygen-dependent inhibition of
neutrophil respiratory burst by nitric oxide. Free Radic Res
1996; 25: 489-98
7. Mercier JC, Lacaze T, Storme L, et al. Disease-related response
to inhaled nitric oxide in newborns with severe hypoxaemic
respiratory failure: French Paediatric Study Group of Inhaled
NO. Eur J Pediatr 1998; 157: 747-52
2
2
3
8. Steinhorn RH, Cox PN, Fineman JR, et al. Inhaled nitric oxide
enhances oxygenation but not survival in infants with alveolar
capillary dysplasia. J Pediatr 1997; 130: 417-22
9. Adler SM, Clark RH. Premature and term neonates have similar
responses to inhaled nitric oxide (iNO) [abstract]. Pediatr Res
1
998; 43: 272A
0. Watchko JF. Persistent pulmonary hypertension in a very low
birthweight preterm infant. Clin Pediatr (Phila) 1985; 24: 592-5
©
Adis International Limited. All rights reserved.
Drugs 2001; 61 (1)